These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 15901584

  • 1. Bevacizumab: improved survival at what cost?
    Kolesar JM.
    Am J Health Syst Pharm; 2005 May 15; 62(10):1017. PubMed ID: 15901584
    [No Abstract] [Full Text] [Related]

  • 2. Bevacizumab treatment for solid tumors: boon or bust?
    Hayes DF.
    JAMA; 2011 Feb 02; 305(5):506-8. PubMed ID: 21285431
    [No Abstract] [Full Text] [Related]

  • 3. 10 Questions about the use of bevacizumab in the management of recurrent malignant gliomas.
    Chamberlain MC.
    Neurologist; 2010 Jan 02; 16(1):56-60. PubMed ID: 20065801
    [No Abstract] [Full Text] [Related]

  • 4. FDA. Once on 'fast track,' avastin now derailed.
    Couzin-Frankel J, Ogale Y.
    Science; 2011 Jul 08; 333(6039):143-4. PubMed ID: 21737712
    [No Abstract] [Full Text] [Related]

  • 5. Position paper: the need for head-to-head studies comparing Avastin versus Lucentis.
    Schmucker C, Antes G, Lelgemann M.
    Surv Ophthalmol; 2009 Jul 08; 54(6):705-7. PubMed ID: 19818262
    [No Abstract] [Full Text] [Related]

  • 6. Avastin hearing leads to more uncertainty over drug's future.
    Goozner M.
    J Natl Cancer Inst; 2011 Aug 03; 103(15):1148-50. PubMed ID: 21768534
    [No Abstract] [Full Text] [Related]

  • 7. Bevacizumab in kidney cancer: new indication. Premature approval of this indication.
    Prescrire Int; 2009 Feb 03; 18(99):10. PubMed ID: 19382401
    [Abstract] [Full Text] [Related]

  • 8. Cancer drug offers effective, cheaper option for AMD.
    Stephenson J.
    JAMA; 2011 May 25; 305(20):2053-4. PubMed ID: 21610231
    [No Abstract] [Full Text] [Related]

  • 9. Avastin's uncertain future in breast cancer treatment.
    Twombly R.
    J Natl Cancer Inst; 2011 Mar 16; 103(6):458-60. PubMed ID: 21393607
    [No Abstract] [Full Text] [Related]

  • 10. Success of bevacizumab trials raises questions for future studies.
    Tuma RS.
    J Natl Cancer Inst; 2005 Jul 06; 97(13):950-1. PubMed ID: 15998941
    [No Abstract] [Full Text] [Related]

  • 11. Reputation and precedent in the bevacizumab decision.
    Carpenter D, Kesselheim AS, Joffe S.
    N Engl J Med; 2011 Jul 14; 365(2):e3. PubMed ID: 21707383
    [No Abstract] [Full Text] [Related]

  • 12. Avastin, ODAC, and the FDA: are we drafting the right players?
    Burstein HJ.
    J Natl Compr Canc Netw; 2010 Aug 14; 8(8):833-4. PubMed ID: 20870630
    [No Abstract] [Full Text] [Related]

  • 13. What is the real cost of bevacizumab for patients with advanced bowel cancer?
    Dixon L.
    Int J Palliat Nurs; 2010 Dec 14; 16(12):577. PubMed ID: 21240100
    [No Abstract] [Full Text] [Related]

  • 14. The use of bevacizumab for the treatment of colorectal cancer.
    Beaumont I.
    Int J Palliat Nurs; 2010 Dec 14; 16(12):576. PubMed ID: 21240099
    [No Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan.
    Shiroiwa T, Fukuda T, Tsutani K.
    Clin Ther; 2007 Oct 14; 29(10):2256-67. PubMed ID: 18042483
    [Abstract] [Full Text] [Related]

  • 16. Maximizing the potential of bevacizumab in cancer treatment.
    Bergsland E, Dickler MN.
    Oncologist; 2004 Oct 14; 9 Suppl 1():36-42. PubMed ID: 15178814
    [Abstract] [Full Text] [Related]

  • 17. [Bevacizumab in the treatment of colorectal carcinoma: news from ASCO 2008].
    Mansueto G, Longo F.
    Tumori; 2008 Oct 14; 94(4):suppl 1-14. PubMed ID: 18822711
    [No Abstract] [Full Text] [Related]

  • 18. Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancer.
    Heinemann V, Hoff PM.
    Oncology; 2010 Oct 14; 79(1-2):118-28. PubMed ID: 21088438
    [Abstract] [Full Text] [Related]

  • 19. Bevacizumab: current updates in treatment.
    Van Meter ME, Kim ES.
    Curr Opin Oncol; 2010 Nov 14; 22(6):586-91. PubMed ID: 20811277
    [Abstract] [Full Text] [Related]

  • 20. Bevacizumab: the need for controlled studies to move forward.
    Buys YM.
    Can J Ophthalmol; 2007 Dec 14; 42(6):789. PubMed ID: 18059506
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.